The clusters and the cluster initiatives of the Russian biopharmaceutical industry: Identifi cation, structure, and geography

Александрова, Екатерина; Ivanova, V.I.; Kuznetsova, Maria Yu.

doi:10.21638/11701/spbu08.2019.302

Cited by 1 publication

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(5) In general, the situation with pharmaceutical clusters in Russia is ambiguous. Due to the interest in clusters and cluster policy that has arisen in the country, there are officially announced clusters, which often do not coincide with the real ones (Aleksandrova et al, 2019). Specialists of the Russian Cluster Observatory, HSE University, 7 cite ten such formally declared pharmaceutical clusters, while speaking about the high level of development of only one: in Obninsk, the average level of development of three more clusters and the low level of development of seven clusters (which most likely prevents us from talking about their actual existence).…”

Section: Resultsmentioning

confidence: 99%

“…In Russia, some exceptions to the general rule are studies on pharmaceutical clusters (Aleksandrova et al, 2019;Bogachev and Rodionova, 2014); however, it seems due more to the prevailing interest in clusters and cluster policy in general in the country than to the pharmaceutical industry as such. There is also an important study from the viewpoint of our research on the development of the pharmaceutical industry in Russia until the early 2000s (Rodionova and Ovcharov, 2001), which gives an idea of the geography of the industry that had developed by that time.…”

Section: Review Of Previous Studiesmentioning

confidence: 99%

See 1 more Smart Citation

Location of the Largest Pharmaceutical Companies in Russia: Contribution to Regional Divergence or Convergence?

Кузнецова

Bobrovsky

2022

Reg. Res. Russ.

View full text Add to dashboard Cite

The objective of the article is to identify factors for the location of pharmaceutical enterprises in Russian regions, including from the viewpoint of assessing the possible contribution of the pharmaceutical industry to the reduction of territorial disproportions in the level of economic development. The pharmaceutical production location factors is analyzed based on a generalization of foreign studies on the topic and a database compiled by the authors on the manufacturing enterprises of more than 50 largest pharmaceutical companies in Russia (taking into account the construction time and large-scale modernization of enterprises belonging to Russian or foreign owners). It is concluded that Russia experiences the same factors of pharmaceutical enterprises' location as abroad: the importance of historically established centers of production is characteristic, including in the eastern regions of the country (due to the reduced role of the transport factor for the industry); preference is often given to expanding capacities of already existing enterprises, instead of construction of new ones; new factories appear on the basis of established pharmaceutical research centers and/or with focus on markets of the largest urban agglomerations and/or in special economic zones and industrial parks. When building new enterprises, investors can seek both to participate in pharmaceutical clusters and save on production costs, including wages, by building factories in areas not saturated in industries. Foreign investment mainly reach only to the western regions of the country due to their capacious sales market and proximity to the countries of origin of companies, which are predominantly European. As a result of numerous factors, the impact of development of pharmaceutical production on territorial disproportions is ambiguous.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Review Of Previous Studiesmentioning

confidence: 99%